HMOX1 and intervertebral disk degenerative disorder: These findings suggest that manipulating HO-1 expression in the intervertebral disc might mitigate the impairment of ECM metabolism resulting from pro-inflammatory cytokine stimulation, and thus could offer a novel therapeutic approach to the treatment of IDD.